CIK 0001840877 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Envoy Medical, Inc.
Sign in to watch- Ticker
- COCH
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861369123
- Phone
- 651-361-8000
- Business address
- 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN, 55110
- Former names
- Anzu Special Acquisition Corp I
Securities
- COCH Class A Common Stock Nasdaq
- COCHW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-15 | Patel Mona Chetan Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-10-15 | Wells David R. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +293,250 | 293,250 | ||
| 2023-10-15 | Smith-Gomez Janis Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Conversion | +2,490,000 | 2,490,000 | ||
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Other disposition | −490,000 | 2,000,000 | ||
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Purchase · Series A Preferred Stock, par value $0.0001 per share | +1,000,000 | $10.00 | $10.0M | 1,000,000 |
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Other acquisition · Series A Preferred Stock, par value $0.0001 per share | +2,500,000 | 2,500,000 | ||
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Returned to the company · Class B Common Stock, par value $0.0001 per share | −5,510,000 | 4,990,000 | ||
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Other disposition · Class B Common Stock, par value $0.0001 per share | −2,500,000 | 2,490,000 | ||
| 2023-09-29 | Anzu SPAC GP I LLC 10% owner | Conversion · Class B Common Stock, par value $0.0001 per share | −2,490,000 | 0 | ||
| 2023-09-29 | Huskins Priya Cherian Director | Conversion | +25,000 | 25,000 | ||
| 2023-09-29 | Huskins Priya Cherian Director | Conversion · Class B Common Stock, par value $0.0001 per share | −25,000 | 0 | ||
| 2023-09-29 | Kantor Susan Director | Conversion | +25,000 | 25,000 | ||
| 2023-09-29 | Kantor Susan Director | Conversion · Class B Common Stock, par value $0.0001 per share | −25,000 | 0 | ||
| 2023-09-29 | Hirsch Daniel J. CFO and Corporate Secretary | Conversion | +25,000 | 25,000 | ||
| 2023-09-29 | Hirsch Daniel J. CFO and Corporate Secretary | Conversion · Class B Common Stock, par value $0.0001 per share | −25,000 | 0 | ||
| 2023-09-29 | DEWBREY DIANE L Director | Conversion | +25,000 | 25,000 | ||
| 2023-09-29 | DEWBREY DIANE L Director | Conversion · Class B Common Stock, par value $0.0001 per share | −25,000 | 0 | ||
| 2023-09-29 | TAYLOR GLEN A Director | Conversion · $10,000,000 Convertible Note | −1,000,000 | $10.00 | $10.0M | 0 |
| 2023-09-29 | TAYLOR GLEN A Director | Conversion · Series A Preferred Stock | +869,565 | $10.00 | $8.7M | 869,565 |
Page 5 of 6 · 103 trades